UA38825A - Method for treating maxillofacial inflammations - Google Patents

Method for treating maxillofacial inflammations

Info

Publication number
UA38825A
UA38825A UA2000106007A UA2000106007A UA38825A UA 38825 A UA38825 A UA 38825A UA 2000106007 A UA2000106007 A UA 2000106007A UA 2000106007 A UA2000106007 A UA 2000106007A UA 38825 A UA38825 A UA 38825A
Authority
UA
Ukraine
Prior art keywords
maxillofacial
inflammations
treating
administration
catheterized
Prior art date
Application number
UA2000106007A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Владислав Олександрович Маланчук
Владислав Александрович Маланчук
Андрій Володимирович Копчак
Андрей Владимирович Копчак
Світлана Анатоліївна Печена
Светлана Анатольевна Печеная
Наталія Олександрівна Гершун
Наталья Александровна Гершун
Дарія Володимирівна Яценко
Дария Владимировна Яценко
Лариса Олександрівна Ліман
Лариса Александровна Лиман
Original Assignee
Національний Медичний Університет Ім. О.О. Богомольця /Нму/
Национальный Медицинский Университет Им. А.А. Богомольца
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Національний Медичний Університет Ім. О.О. Богомольця /Нму/, Национальный Медицинский Университет Им. А.А. Богомольца filed Critical Національний Медичний Університет Ім. О.О. Богомольця /Нму/
Priority to UA2000106007A priority Critical patent/UA38825A/en
Publication of UA38825A publication Critical patent/UA38825A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The method for treating maxillofacial inflammations provides for round-the-clock intraarterial administration of ozonized physiologic saline containing 0.5-5 mg/l of ozone through the catheterized superficial temporal artery in dropwise mode for 2-5 days. Then fractional administration follows twice a day until the arrest of exudation.
UA2000106007A 2000-10-24 2000-10-24 Method for treating maxillofacial inflammations UA38825A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UA2000106007A UA38825A (en) 2000-10-24 2000-10-24 Method for treating maxillofacial inflammations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UA2000106007A UA38825A (en) 2000-10-24 2000-10-24 Method for treating maxillofacial inflammations

Publications (1)

Publication Number Publication Date
UA38825A true UA38825A (en) 2001-05-15

Family

ID=74217341

Family Applications (1)

Application Number Title Priority Date Filing Date
UA2000106007A UA38825A (en) 2000-10-24 2000-10-24 Method for treating maxillofacial inflammations

Country Status (1)

Country Link
UA (1) UA38825A (en)

Similar Documents

Publication Publication Date Title
GB0025173D0 (en) Therapeutic agents
NO20075065L (en) Use of isoflavone compounds to treat heart disease
BG102619A (en) Substituted n-[(aminoiminomethyl or aminomethyl) phenyl] propylamides
DE69531457D1 (en) Sulfonamide
DE69625691D1 (en) ADMINISTRATION OF PEPTIDYLHETEROCYCLES FOR THE TREATMENT OF THROMBINE IN RELATED DISEASES
CY2473B1 (en) New phenanthridines.
GB0225474D0 (en) Therapeutic agents
BR0008176A (en) Anti-seizure derivatives useful in the treatment of cluster headaches
NZ516349A (en) Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease
SE9404196D0 (en) New antithrombotic formulation
IL138665A0 (en) Peptide factor
GR3033846T3 (en) Imidazopyridines and their use in treating gastrointestinal diseases.
IL152770A0 (en) Gabapentin analogues for sleep disorders
CY2431B1 (en) Novel phenanthridines substituted in the 6 position.
EA200400548A1 (en) TREATMENT OF HEAVY PNEUMONIA THROUGH THE INTRODUCTION OF THE TISSUE FACTOR INHIBITOR (TFPI)
IS5273A (en) Therapeutic treatment, contained in CD 154 inhibition, for therapeutic protein bar syndrome
TR199701121T1 (en) Benazepril or combination compositions containing benazepril and valsartan.
MX9709466A (en) Methods of inhibiting melanoma.
UA38825A (en) Method for treating maxillofacial inflammations
ZA923935B (en) New 2-amino-5-cyano-1,4-dihydropyridines,processes for their preparation and their use in medicaments
WO1991015466A3 (en) Aminopolycarboxylic acid chelating agents
GB9420747D0 (en) 1,5 benzodiazepine derivatives
BG102087A (en) The use of pyrrolidine derivatives for the treatment of alcoholism
PL367630A1 (en) Use of acetyl l-carnitine in association with the biotin for the treatment of patients with type 2 insulin-resistant diabetes mellitus
IT1242475B (en) COLINERGIC AGENT, IN PARTICULAR GLYCIL-P-AMINO-PYRIDINE-ANYLIDE-MONOACETATE, FOR THE TREATMENT OF SENILE STATE OF DEEMENT.